IP Verse

Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof

Patent No. EP2682388 (titled "Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof") was filed by Mylan Laboratories on Jun 22, 2009. The application was issued on Jan 10, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOEFER & PARTNER PATENTANWALTE MBBOct 10, 2018HOEFER & PARTNER PATENTANWALTE MBB
LES LABORATOIRES SERVIEROct 10, 2018-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2682388

MYLAN LABORATORIES
Application Number
EP13003519A
Filing Date
Jun 22, 2009
Status
Revoked
Apr 3, 2020
Publication Date
Jan 10, 2018
External Links
Slate, Register , Google Patents